TRIPAWDS: Home to 22971 Members and 2152 Blogs.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG

Caring for a Three Legged Dog or Cat

Tripawds is your home to learn how to care for a three legged dog or cat, with answers about dog leg amputation, and cat amputation recovery from many years of member experiences.

JUMP TO FORUMS

Join The Tripawds Community

Learn how to help three legged dogs and cats in the forums below. Browse and search as a guest or register for free and get full member benefits:

Instant post approval.

Private messages to members.

Subscribe to favorite topics.

Live Chat and much more!

Please consider registering
Guest
Search
Forum Scope


Match



Forum Options



Minimum search word length is 3 characters - maximum search word length is 84 characters
Register Lost password?
sp_Feed sp_PrintTopic sp_TopicIcon-c
Promising New Mast Cell Cancer Treatment
sp_NewTopic Add Topic
On The Road


Member Since:
24 September 2009
sp_UserOfflineSmall Offline
1
6 July 2020 - 10:44 am
sp_Permalink sp_Print sp_QuotePost

This just in from Australia:

PROMISING NEW CANCER TREATMENT FOR DOGS WITH MAST CELL TUMOURS

Results published today reveal QBiotics’ STELFONTA® removes 75% of tumours

The Journal of Veterinary Internal Medicine has today published results from a pivotal canine field study of STELFONTA® (tigilanol tiglate), the lead anticancer pharmaceutical from Australian life sciences company, QBiotics Group Limited (QBiotics).

The study of 123 client-owned dogs demonstrated that in those with Mast Cell Tumours (MCTs), a single intratumoural injection of STELFONTA® removed 75% of MCTs at day 28, significantly higher compared to untreated controls (p<0.001). Further, the trial showed no recurrence in 93% of STELFONTA®-treated dogs at day 84. Importantly, the treatment was well tolerated, and animals had a good quality of life during and after treatment.[1] 

STELFONTA® is a first-in-class pharmaceutical treatment for all grades of MCT now available in Europe with anticipated launches in the USA and Australia, pending approvals.

Dr Chad Johannes, a leading USA veterinary oncologist said, “The study determined STELFONTA® is an efficacious and well-tolerated new option for the local treatment of canine MCT.

“STELFONTA® is administered by injection directly into the tumour. Generally, dogs undergoing treatment do not require sedation or anaesthesia, which carries potential increased risk for older dogs and brachycephalic breeds,” said Dr Johannes. 

READ MORE

Tripawds Founders Jim and Rene
tripawds.com | tripawds.org | bemoredog.net | triday.pet

Howard Hulme
2
19 September 2020 - 1:30 pm
sp_Permalink sp_Print sp_QuotePost

Do you have any information on the approval of Stelfonta in the US?

On The Road


Member Since:
24 September 2009
sp_UserOfflineSmall Offline
3
19 September 2020 - 4:41 pm
sp_Permalink sp_Print sp_QuotePost

We haven't heard anything Howard, and a quick Google search shows it's still not approved for use here. Hopefully soon!

Tripawds Founders Jim and Rene
tripawds.com | tripawds.org | bemoredog.net | triday.pet

Howard Hulme
4
20 September 2020 - 6:51 am
sp_Permalink sp_Print sp_QuotePost

Thank you.  Our 12+ lab has what is suspected to be a mast cell tumor on her shoulders.  No biopsy taken because our vet believes her health is such that she would not survive surgery.  Stelfonta may give her a treatment option.

Forum Timezone: America/Denver
Most Users Ever Online: 946
Currently Online: jerry
Guest(s) 129
Currently Browsing this Page:
1 Guest(s)
Member Stats:
Guest Posters: 1268
Members: 17733
Moderators: 6
Admins: 3
Forum Stats:
Groups: 4
Forums: 24
Topics: 18610
Posts: 256801
Administrators: admin, jerry, Tripawds
Tripawds is brought to you by Tripawds.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG